
浏览全部资源
扫码关注微信
纸质出版:2009
移动端阅览
王法祥,彭国光,王加才,王少君,何卿玮.优化hα-syn基因疫苗预防注射对MPTP急性帕金森病小鼠的神经保护作用[J].陆军军医大学学报(原第三军医大学学报),2009,31(18):1761-1765.
WANG Fa-xiang,PENG Guo-guang,WANG Jia-cai,WANG Shao-jun,HE Qing-wei.Preventative immunization of optimized human α-synuclein DNA vaccine protects acute mouse with MPTP-induced Parkinson’s disease[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(18):1761-1765.
王法祥,彭国光,王加才,王少君,何卿玮.优化hα-syn基因疫苗预防注射对MPTP急性帕金森病小鼠的神经保护作用[J].陆军军医大学学报(原第三军医大学学报),2009,31(18):1761-1765. DOI:
WANG Fa-xiang,PENG Guo-guang,WANG Jia-cai,WANG Shao-jun,HE Qing-wei.Preventative immunization of optimized human α-synuclein DNA vaccine protects acute mouse with MPTP-induced Parkinson’s disease[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(18):1761-1765. DOI:
目的 探讨预防注射优化hα-syn基因疫苗对多巴胺神经元在遭受急性神经毒素损害时的保护作用。 方法 在小鼠双侧后肢胫骨前肌部位分别注射优化基因疫苗、空重组质粒或PBS各50 μl,共3次。末次注射3周后,优化基因疫苗组皮下注射MPTP 30 mg/kg
对照组用等容量的PBS背部皮下注射,每日1次,连续5 d。最后1次模型注射后,观察行为学和病理生理改变。 结果 优化基因疫苗组小鼠的爬杆分数与空重组质粒组比较明显减少(P0.05),与PBS对照组比较,爬杆分数增多,但差异无统计学意义(P0.05)。优化基因疫苗组与空重组质粒组相比,黑质区酪氨酸羟化酶阳性细胞数明显增多,凋亡细胞数明显减少(P0.05),α-突触核蛋白表达略减少(P0.05)。空重组质粒组与PBS对照组相比,黑质区酪氨酸羟化酶阳性细胞数明显减少,凋亡细胞明显增多(P0.05),α-突触核蛋白表达明显增多(P0.05)。 结论 优化hα-syn基因疫苗预防注射能够较好的防止神经毒素对黑质多巴胺细胞的损害,对多巴胺神经细胞具有保护作用。
Objective To explore the neuroprotective effects of optimized human α-synuclein DNA vaccine on dopaminergic neurons after acute neurotoxin damage. Methods Totally 24 C57BL/6J mice were randomly divided into 3 groups: the optimized human α-synuclein (α-syn) DNA vaccine group (pVAX1-Igk-hαS1-140)
the empty plasmid group (pVAX1)
and the PBS group. Before the immunizing of mice every time
anterior tibial muscles of mice hind legs were respectively injected with 50 μl 0.5% bupivacaine unilaterally. In 72 h later
those mice were injected unilaterally at t
he same site and in the same depth with 50 μl corresponding agents. The immunization was given once every three weeks for totally 3 times. Two weeks after the last immunization
those mice of pVAX1-Igk-hαS1-140 group and pVAX1 group were intraperitoneally injected with 250 mg/kg probenecid followed by injection with MPTP (25 mg·kg
-1
·d
-1
×5 d
s.c.; dissolved in 0.9% NS) in the back
and those mice of PBS group were injected with the same volume of PBS. The mice were sacrificed on the second day after last MPTP injection and their brain was taken out for immunofluorescence and immunostaining. From the next day after the last immunization injection to the day of death
the behavior of all mice were observed by pole testing. Results Compared with empty plasmid group
the scores of pole test of pVAX1-Igk-hαS1-140 DNA vaccine group was decreased with significant differences (P0.05). Compared with PBS group
the scores of pole test were increased but there was no significance differences (P0.05). Compared with empty plasmid group
the number of tyrosine hydroxylase-positive cells of pVAX1-Igk-hαS1-140 DNA vaccine group was increased and that of apoptotic cells was decreased significantly (P0.05). At the same time
the number of α-synuclein expression-positive cells was decreased for a little
but there was no statistically significant difference (P0.05). Compared with PBS group
the number of tyrosine hydroxylase-positive cells of empty plasmid group was decreased and that of apoptosis cells was increased significantly (P0.05). At the same time
the number of α-synuclein-positive cells was increased significantly (P0.05). Conclusion The optimized DNA vaccine improves the behavior of mice with Parkinson’s disease
and at the same time it plays a positive role in strengthening immunogenicity and exerting neuroprotective effects on dopaminergic neuron against acute neurotoxin damage.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621